ATIM-11. TUMOR-INFILTRATING LYMPHOCYTES EXPRESSING ANTI-PD-1 ANTIBODY EXHIBIT A PROMISING EFFICACY AND SURVIVAL BENEFIT IN PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME
Chao Tang(North Sichuan Medical University), Liang Zhou(Eye & ENT Hospital of Fudan University), Chunxia Ji(Shanghai Public Health Clinical Center), Fei Xu(Sun Yat-sen University), Wen Qin(Air Force Medical University), Kai Ji(Tianjin Medical University Cancer Institute and Hospital), Hua Jin(Anhui University of Traditional Chinese Medicine), Di Chen(Fudan University), Xiao Liu(Beijing Forestry University), Chen Ling, Qiqi Lu(Fudan University), Qi Qian(Shanghai Cell Therapy Research Institute), Zhi Zhang(Ministry of Agriculture and Rural Affairs), Wen‐Jang Chu(University of Alabama at Birmingham), Yu Yao(Qinghai University)
Cited by 0
Related Papers
The path to healthy ageing in China: a Peking University–Lancet Commission
|The Lancet|2022|955
CGCG clinical practice guidelines for the management of adult diffuse gliomas
|Cancer Letters|2016|650
A global reference for human genetic variation
|Civil War Book Review|2015|612
Clinical practice guidelines for the management of adult diffuse gliomas
|Cancer Letters|2020|482